home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  June 20, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 463 active entries


Genavenir 8 - 5, rue Henri Desbruères
Evry, 91030

Phone: +33 1 60 91 21 21
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Biomehodes is a technological leader in directed evolution and protein engineering.

We have developed Massive Mutagenesis®, the only high throughput combinatorial site-directed mutagenesis technology, with a main application to direct molecular evolution of industrial enzymes and therapeutic proteins.

This technology allows the generation of complex protein variants at a high throughput and has been widely validated through over 30 research projects.

Key words:

Molecular Evolution; Mutagenesis; High-throughput Screening; Bioinformatics; Industrial Enzymes
Therapeutic Proteins; Recombinant Antibodies

Selected Categories:

Product Company   Service Company
- Research
- Research
- Research
- Services

Last update of this entry: November 15, 2005

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.